Today's biggest movers. Our screens cover mega-cap down to micro-cap and surface the catalyst behind the move.
200 articles
TeraWulf Inc. (WULF) jumps after announcing a 20-year lease with Anthropic that could generate about $19 billion in contracted revenue. The deal, plus a majority stake sale in its Abernathy JV, strengthens the company’s AI infrastructure pivot and gives investors a clearer long-term growth story.
Intuitive Surgical, Inc. (ISRG) rises sharply on above-average volume as investors react to strong procedure growth, da Vinci 5 adoption, and supportive sentiment. With no fresh earnings or FDA catalyst, the move appears tied to operating momentum, index-related flows, and renewed demand for quality healthcare growth.
Micron Technology, Inc. (MU) drops after a huge AI-driven rally, even as recent earnings, analyst upgrades, and new strategic deals remain strong. The move looks more like profit-taking and crowded positioning than a fundamental setback, with investors reassessing how much optimism is already priced in.
Tesla, Inc. (TSLA) drops sharply after a record Q2 2026 delivery report sparked a sell-the-news reversal. Shares fell 7.49% on heavy volume even as deliveries beat estimates, highlighting investor concern that Tesla’s rich valuation still needs stronger margins and earnings power to hold gains.
Intel Corp. (INTC) drops after a broad semiconductor selloff and profit-taking hit chip stocks across the board. Even a fresh bullish analyst upgrade could not offset valuation worries, making the move look more like sector de-risking than a company-specific setback.
AstraZeneca PLC (AZN) rises after a new kidney disease partnership with CSPC Pharmaceutical Group sparked investor interest. The large-cap drugmaker’s move reflects confidence in its pipeline strategy, with the stock trading on solid volume and supported by a broad, diversified business model.
Vertex Pharmaceuticals Incorporated (VRTX) rises after the FDA expanded CASGEVY use to younger patients, widening the therapy’s addressable market. The move lifts the stock toward its 52-week high and reinforces Vertex’s growth story beyond cystic fibrosis.
Intel Corp. (INTC) drops after an early rally reversed into a broad semiconductor selloff. A bullish HSBC price-target hike initially lifted shares, but profit-taking and sector weakness overwhelmed the stock’s momentum. The move looks more like a valuation reset than a company-specific setback.
Vertex Pharmaceuticals Incorporated (VRTX) rises after the FDA expands CASGEVY for younger patients with sickle cell disease and beta thalassemia. The approval widens the therapy’s addressable market, strengthens Vertex’s rare-disease growth story, and sends the stock to a fresh 52-week high.
S&P Global Inc. (SPGI) rises sharply after completing the spin-off of its Mobility business into Mobility Global Inc. The move reflects post-separation repricing as investors reassess the value of SPGI’s core ratings, indices, and data franchises.
Netflix, Inc. (NFLX) rises sharply as investors reverse a recent selloff tied to acquisition speculation. Relief over fading NBCUniversal deal fears, plus a valuation reset near recent lows, helped fuel the rebound despite a slightly weaker Nasdaq session.
Micron Technology, Inc. (MU) drops sharply as investors lock in gains after a strong earnings run and broader weakness hits memory and AI chip stocks. Despite the pullback, recent results, analyst upgrades, and new customer deals keep the long-term AI memory story intact.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator